In this issue:
TORPEdO: IMPT vs. IMRT in oropharyngeal SCC
IMPT vs. IMRT for oropharyngeal cancer
Outpatient low-dose immunotherapy + oral metronomic therapy + chemotherapy in borderline resectable oral cavity SCC
MRLN-sparing radiotherapy for non-metastatic nasopharyngeal carcinoma
CAPTAIN-1st: camrelizumab + chemotherapy in nasopharyngeal carcinoma
FRAIL-IMMUNE: durvalumab + carboplatin/paclitaxel in frail, cisplatin-ineligible HNSCC
A proposed staging system for salivary gland carcinoma
LEAP-010: lenvatinib + pembrolizumab in PD-L1 CPS ≥1 HNSCC
Association between ORR & survival in HNSCC treated with ICIs/cetuximab-based therapy
OMET: OS with SABR protocol deviations in oligometastatic HNSCC
Supportive care referrals for head & neck cancer
Please login below to download this issue (PDF)